Viewing Study NCT02826161

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:52 AM
Ignite Modification Date: 2026-01-29 @ 5:30 PM
Study NCT ID: NCT02826161
Status: TERMINATED
Last Update Posted: 2023-11-15
First Post: 2016-07-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer
Sponsor: Sumitomo Pharma America, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoplasms View
None Neoplasms by Site View
None Lung Neoplasms View
None Thoracic Neoplasms View
None Respiratory Tract Neoplasms View
None Bronchial Neoplasms View